The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Sarwar, Shahbaz
    Company Director born in July 1981
    Individual (1 offspring)
    Officer
    2020-09-02 ~ now
    OF - director → CIF 0
    Mr Shahbaz Sawar
    Born in July 1981
    Individual (1 offspring)
    Person with significant control
    2022-01-10 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Bentley, Alan Richard
    Director born in February 1970
    Individual (2 offsprings)
    Officer
    2023-03-31 ~ now
    OF - director → CIF 0
  • 3
    Vijayabaskar, Aravindhan
    Director born in April 1976
    Individual (4 offsprings)
    Officer
    2024-11-01 ~ now
    OF - director → CIF 0
  • 4
    Rawlins, Gaynor
    Director born in August 1963
    Individual (2 offsprings)
    Officer
    2022-01-10 ~ now
    OF - director → CIF 0
  • 5
    Naqesh-bandi, Mariam
    Director born in August 1989
    Individual (1 offspring)
    Officer
    2022-01-11 ~ now
    OF - director → CIF 0
Ceased 4
  • 1
    Holder, Michael
    Director born in April 1961
    Individual (284 offsprings)
    Officer
    2009-09-03 ~ 2009-09-03
    OF - director → CIF 0
  • 2
    Hayes, Robert Jeremy
    Chartered Engineer born in September 1956
    Individual (1 offspring)
    Officer
    2009-09-03 ~ 2020-09-02
    OF - director → CIF 0
    Mr Robert Jeremy Hayes
    Born in September 1956
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ 2020-09-02
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    PE - Has significant influence or control → CIF 0
  • 3
    Ault, Madeleine, Ms.
    Company Director born in April 1960
    Individual
    Officer
    2020-09-02 ~ 2024-10-31
    OF - director → CIF 0
    Ms. Madeleine Ault
    Born in April 1960
    Individual
    Person with significant control
    2020-09-02 ~ 2023-03-31
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 4
    Naqesh-bandi, Mariam
    Director born in July 1989
    Individual (1 offspring)
    Officer
    2022-01-10 ~ 2022-01-10
    OF - director → CIF 0
parent relation
Company in focus

PHARMA SYSTEMS INTERNATIONAL (UK) LIMITED

Standard Industrial Classification
96090 - Other Service Activities N.e.c.
Brief company account
Average Number of Employees
02022-10-01 ~ 2023-09-30
02021-10-01 ~ 2022-09-30
Par Value of Share
Class 1 ordinary share
12022-10-01 ~ 2023-09-30
Property, Plant & Equipment
54 GBP2023-09-30
184 GBP2022-09-30
Debtors
61,819 GBP2023-09-30
100,367 GBP2022-09-30
Cash at bank and in hand
69,472 GBP2023-09-30
68,452 GBP2022-09-30
Current Assets
131,291 GBP2023-09-30
168,819 GBP2022-09-30
Creditors
Current
90,650 GBP2023-09-30
101,439 GBP2022-09-30
Net Current Assets/Liabilities
40,641 GBP2023-09-30
67,380 GBP2022-09-30
Total Assets Less Current Liabilities
40,695 GBP2023-09-30
67,564 GBP2022-09-30
Equity
Called up share capital
100 GBP2023-09-30
100 GBP2022-09-30
Capital redemption reserve
60 GBP2023-09-30
60 GBP2022-09-30
Retained earnings (accumulated losses)
40,535 GBP2023-09-30
67,404 GBP2022-09-30
Equity
40,695 GBP2023-09-30
67,564 GBP2022-09-30
Property, Plant & Equipment - Gross Cost
Computers
389 GBP2022-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
335 GBP2023-09-30
205 GBP2022-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers
130 GBP2022-10-01 ~ 2023-09-30
Property, Plant & Equipment
Computers
54 GBP2023-09-30
184 GBP2022-09-30
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
56,733 GBP2023-09-30
99,219 GBP2022-09-30
Other Debtors
Current, Amounts falling due within one year
5,086 GBP2023-09-30
1,148 GBP2022-09-30
Debtors
Current, Amounts falling due within one year
61,819 GBP2023-09-30
100,367 GBP2022-09-30
Trade Creditors/Trade Payables
Current
16,903 GBP2023-09-30
10,001 GBP2022-09-30
Other Taxation & Social Security Payable
Current
18,117 GBP2023-09-30
28,231 GBP2022-09-30
Other Creditors
Current
55,630 GBP2023-09-30
63,207 GBP2022-09-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1 shares2023-09-30
  • PHARMA SYSTEMS INTERNATIONAL (UK) LIMITED
    Info
    Registered number 07008411
    Finlayson & Co Whitby Court, Abbey Road Shepley, Huddersfield HD8 8EL
    Private Limited Company incorporated on 2009-09-03 (15 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-18
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.